Sucralfate
NDC Package 17856-1011-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Sucralfate is a medication used to treat and prevent ulcers in the intestines. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-1011 and is authorized under FDA application NDA019183.

Identification & Billing

NDC Package Code
17856-1011-1
Package Description
72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE / 10 mL in 1 CUP, UNIT-DOSE (17856-1011-2)
Product Code
11-Digit Billing Format
17856101101

Clinical Specifications

Proprietary Name
Sucralfate
Dosage Form
-
Usage Information
This medication is used to treat and prevent ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.

Regulatory & Marketing

Labeler Name
Atlantic Biologicals Corp.
FDA Application #
NDA019183
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
01-27-2020
End Marketing Date
02-28-2025
Listing Expiration
02-28-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-1011-1 identifies a specific commercial package of 72 cup, unit-dose in 1 box, unit-dose / 10 ml in 1 cup, unit-dose (17856-1011-2) of Sucralfate, labeled by Atlantic Biologicals Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corp. on January 27, 2020. The current certification is valid through February 28, 2025.

What are the primary indications for this medication?

This medication is used to treat and prevent ulcers in the intestines. Sucralfate forms a coating over ulcers, protecting the area from further injury. This helps ulcers heal more quickly.

How is this Atlantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856101101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-1011-1
11-Digit CMS (5-4-2)
17856-1011-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.